Sex Differences in Time-Series Changes in Pseudo-R2 Values Regarding Hyperuricemia in Relation to the Kidney Prognosis
Authors:
- Hiroshi KataokaHKHiroshi Kataoka
- Mamiko OharaMOMamiko Ohara
- Toshio MochizukiTMToshio Mochizuki
- Kazuhiro IwadohKIKazuhiro Iwadoh
- Yusuke UshioYUYusuke Ushio
- Keiko KawachiKKKeiko Kawachi
- Kentaro WatanabeKWKentaro Watanabe
- Saki WatanabeSWSaki Watanabe
- Taro AkihisaTATaro Akihisa
- Shiho MakabeSMShiho Makabe
- Shun ManabeSMShun Manabe
- Masayo SatoMSMasayo Sato
Open Access
- 26 November 2020
- journal article
- research article
- Published by MDPI AG in Journal of Personalized Medicine
- Vol. 10 (4) , 248
Abstract
Studies on sex differences in time-series changes in pseudo-R2 values regarding hyperuricemia (HU) in relation to the kidney prognosis among patients with chronic kidney disease (CKD) are scant. The kidney prognosis was evaluated in 200 patients with CKD (median follow-up, 12.3 years). Survival analyses and logistic regression analyses were conducted, generating time-series pseudo-R2 values. We used four definitions of HU according to serum uric acid (SUA) levels (HU6, SUA ≥ 6.0 mg/dL; HU7, SUA ≥ 7.0 mg/dL; HU8, SUA ≥ 8.0 mg/dL) and antihyperuricemic agent use to calculate the mean and percentage of the change in pseudo-R2 values from the 6th year until the end of the study (6Y–End Mean and 6Y–End Change, respectively). The multivariable Cox regression analysis showed that HU7 was significantly associated with kidney outcomes. When stratified by sex, the 6Y–End Mean was clearly higher in women than in men for all HU definitions, with the highest value (0.1755) obtained for HU7 in women. The pseudo-R2 values for HU6 in women showed an increasing pattern, with a 6Y–End Change of 11.4%/year. Thus, it may be clinically meaningful to consider sex differences in the time-series pseudo-R2 values regarding HU and kidney outcomes.Keywords
This publication has 64 references indexed in Scilit:
- Concepts of comorbidities, multiple morbidities, complications, and their clinical epidemiologic analogsClinical Epidemiology, 2013
- Patient-centered medicine and patient-oriented research: improving health outcomes for individual patientsBMC Medical Informatics and Decision Making, 2013
- An association between uric acid levels and renal arteriolopathy in chronic kidney disease: a biopsy-based studyHypertension Research, 2012
- Revised Equations for Estimated GFR From Serum Creatinine in JapanAmerican Journal of Kidney Diseases, 2009
- Serum Uric Acid as a Predictor for Development of Diabetic Nephropathy in Type 1 DiabetesDiabetes, 2009
- Uric Acid and Long-term Outcomes in CKDAmerican Journal of Kidney Diseases, 2009
- Risk Factors for End-Stage Renal DiseaseArchives of internal medicine (1960), 2009
- Uric acid as a risk factor for progression of non-diabetic chronic kidney disease? The Mild to Moderate Kidney Disease (MMKD) StudyExperimental Gerontology, 2008
- Uric acid stimulates vascular smooth muscle cell proliferation and oxidative stress via the vascular renin–angiotensin systemJournal Of Hypertension, 2008
- Uric Acid Stimulates Monocyte Chemoattractant Protein-1 Production in Vascular Smooth Muscle Cells Via Mitogen-Activated Protein Kinase and Cyclooxygenase-2Hypertension, 2003